Literature DB >> 7496962

Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.

H E Prince1, J York, J Golding, S M Owen, R B Lal.   

Abstract

Spontaneous lymphocyte proliferation (SLP) during in vitro culture of mononuclear cells (MCs) characterizes over half of asymptomatic individuals infected with human T-cell lymphotropic virus type I (HTLV-I) or HTLV-II. Both CD4 and CD8 T-cell subsets within MC cultures are activated during SLP, as judged by high-density CD25 (CD25bright) expression; it is unclear, however, whether both cell subsets can directly undergo SLP. In the present investigation, the SLP capacities of purified CD8 and CD4 cells were examined in subjects infected with HTLV-I (n = 19) or HTLV-II (n = 54) in relation to the SLP status of MCs from each subject. No increase in SLP was observed for CD8 or CD4 cells from SLP-negative (SLP-) HTLV-infected subjects, whereas robust SLP characterized CD8 cells from all SLP-positive (SLP+) individuals, regardless of HTLV type. In contrast, SLP+ CD4 cells characterized only 23% (7 of 31) of HTLV-II+ SLP+ individuals, whereas SLP+ CD4 cells characterized 100% of HTLV-I+ SLP+ individuals. In cocultures of HTLV-II+ SLP+ CD8 cells and autologous SLP- CD4 cells, sizable proportions of both CD8 cells and CD4 cells coexpressed CD25bright, suggesting that SLP- CD4 cells were activated in the presence of SLP+ CD8 cells. PCR analysis for tax sequences detected provirus in most CD4- and CD8-cell preparations from HTLV-seropositive individuals, regardless of type and the SLP status of cell subsets. To determine whether SLP was associated with activation of viral genes, levels of HTLV-I and HTLV-II core antigen (Ag) in supernatants were measured. Viral Ag production and SLP responses were significantly correlated for both CD4 and CD8 cells in both HTLV-I and HTLV-II infections. However, inhibition of CD8- or CD4-cell SLP by cyclosporin A or anti-Tac (anti-CD25) did not reduce Ag production, indicating that Ag production is not coupled to SLP. These findings show that CD4 cells from SLP+ HTLV-I+ and SLP+ HTLV-II+ individuals differ in SLP capacity, that the absence of SLP does not indicate a lack of infection, and that production of viral Ag is associated with, but not dependent on, SLP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496962      PMCID: PMC368248          DOI: 10.1128/cdli.1.3.273-282.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  Healthy HTLV-I carriers in Japan: the haematological and immunological characteristics.

Authors:  K Yasuda; Y Sei; M M Yokoyama; K Tanaka; A Hara
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

Review 2.  Infection with HTLV-I and HTLV-II: evolving concepts.

Authors:  J D Rosenblatt; I S Chen; W Wachsman
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

Review 3.  Manifestations of human T-lymphotropic virus type I infection.

Authors:  J H Kim; D T Durack
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

4.  A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.

Authors:  L A Rubin; C C Kurman; W E Biddison; N D Goldman; D L Nelson
Journal:  Hybridoma       Date:  1985

5.  Spontaneous lymphocyte proliferation in human T lymphotropic virus type II infection is associated with increased provirus load.

Authors:  H E Prince; P Swanson
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

6.  Simultaneous determination of absolute total lymphocyte and CD4+ lymphocyte levels in peripheral blood by flow cytometry.

Authors:  H E Prince; W J Lesar
Journal:  Am J Clin Pathol       Date:  1989-08       Impact factor: 2.493

7.  Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.

Authors:  Y Itoyama; S Minato; J Kira; I Goto; H Sato; K Okochi; N Yamamoto
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

8.  Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.

Authors:  S Jacobson; V Zaninovic; C Mora; P Rodgers-Johnson; W A Sheremata; C J Gibbs; C Gajdusek; D E McFarlin
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

9.  Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

Authors:  A E Williams; C T Fang; D J Slamon; B J Poiesz; S G Sandler; W F Darr; G Shulman; E I McGowan; D K Douglas; R J Bowman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

10.  High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis.

Authors:  A Gessain; F Saal; O Gout; M T Daniel; G Flandrin; G de The; J Peries; F Sigaux
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

View more
  13 in total

1.  Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  M Makino; M Azuma; S I Wakamatsu; Y Suruga; S Izumo; M M Yokoyama; M Baba
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

3.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 4.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

5.  Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals.

Authors:  M Suzuki; C S Dezzutti; A Okayama; N Tachibana; H Tsubouchi; N Mueller; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease.

Authors:  Y S Ding; S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2.

Authors:  E S Trueblood; W C Brown; G H Palmer; W C Davis; D M Stone; T F McElwain
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Mindy Stamer; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

9.  Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.

Authors:  H E Prince; J York; S M Owen; R B Lal
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2.

Authors:  Jianxin Ye; Li Xie; Patrick L Green
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.